Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net (loss) income	$ (71,901)	$ 12,643
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Amortization of premium or discount on fixed maturity securities	454	1,350
Net realized (gain) on sale of investments	(319)	(434)
Unrealized loss on trading securities	311	651
Unrealized loss on derivative liability - embedded conversion feature	65,917
Equity-based compensation expense	961	600
Changes in assets and liabilities:
Accrued investment income	193	379
Other assets	17	472
Change in cash equivalents held in trust	5,769	22,649
Change in restricted cash	(579,927)	71
Losses and loss adjustment reserves	(12,365)	(22,148)
Losses payable	(550)	(1,875)
Unearned premiums	(258)	(238)
Accrued ceding commission expense	(8)	(54)
Accrued interest on notes payable	(26)	(814)
Loss contract fair market value reserve	(2,783)	(30,287)
Other liabilities	11,886	(710)
Total adjustments	(510,728)	(30,388)
Net cash (used in) operating activities:	(582,629)	(17,745)
Cash flows from investing activities:
Purchase of investments	(202,398)	(431,113)
Proceeds from sales and maturities of investments	156,588	511,331
Net cash (used in) provided by investing activities:	(45,810)	80,218
Cash flows from financing activities:
Proceeds from issuance of preferred stock and warrants to purchase common stock	600,000	22,572
Fees incurred and paid relating to preferred stock and warrant issuance	(19,310)	(3,348)
Redeemable convertible series B preferred stock dividends paid in cash	(12,498)
Deferred offering costs		(12,166)
Notes payable – principal repayments	(3,330)	(78,890)
Notes payable – principal issued	918	3,718
Net cash provided by (used in) financing activities:	565,780	(68,114)
(Decrease) in cash and cash equivalents	(62,659)	(5,641)
Cash and cash equivalents, beginning of period	78,009	11,986
Cash and cash equivalents, end of period	15,350	6,345
Supplementary disclosure of cash flow information:
Cash paid during the period, Interest	1,951	5,094
Supplementary disclosure of non-cash investing and financing activities:
Embedded derivatives on preferred stock issuances	66,227
Notes payable issued in lieu of cash interest payments	918	3,718
Non-cash redeemable convertible series B preferred stock dividends accrued	750
Accrued fees relating to series B preferred stock issuance	$ 12,250
Preferred deemed dividend recorded due to beneficial conversion feature		$ 9,455